Lipid Disorders
Conference Coverage
Elevated CRP and mortality risk differs by gender, race
LOS ANGELES – The risk was highest for non-Hispanic black men and in Mexican-American females.
Conference Coverage
Novel metabolic biomarkers linked to CHD
ANAHEIM, CALIF. – The new findings “demonstrate the value of metabolomics for biomarker discovery and improved risk stratification,” said lead...
From the Journals
Type 2 diabetes remitted with low-calorie diet
Following a low-calorie diet for 1 year is enough to reverse type 2 diabetes.
Conference Coverage
Shift to long-term ‘maternal care’ needs boost
WASHINGTON – “We need regular screening of women” to prevent long-term metabolic and cardiovascular disorders, said Dr. George R. Saade.
Conference Coverage
VIDEO: Canakinumab’s cardiovascular benefits linked with hsCRP cuts
ANAHEIM, CALIF. – Response in the inflammation marker hsCRP tracked with reduced CVD risk.
Conference Coverage
ACA repeal could mean financial ruin for many MI, stroke patients
ANAHEIM, CALIF. – Investigators weighed median hospital charges for AMI and stroke against census and labor statistics data.
Conference Coverage
Statin didn’t slow hepatic steatosis in HIV patients
SAN DIEGO – HIV patients taking a statin saw greater hepatic steatosis progression than did placebo patients.
Conference Coverage
Large database analysis suggests safety of bariatric surgery in seniors
The risk may be considered acceptable in relation to the potential health benefits.
Conference Coverage
Targeting PCSK9 inhibitors to reap most benefit
ANAHEIM, CALIF. – New FOURIER analyses show where evolocumab packs greatest payoff.
Conference Coverage
Psych evaluation identifies bariatric surgery patients who do less well
Bariatric surgery is an emotional ordeal and psychological testing prior to the event can flag those who may need more support once the deed is...
Conference Coverage
Late-Breaking Science preview: Monday, Nov. 13
Monday at AHA is packed with three Late-Breaking Science sessions, with many presentations providing new insights into blockbuster megatrials.